Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,917 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Response to: 'COVID-19 in patients with rheumatological diseases treated with Anti-TNF' by Brito et al and 'Clinical characteristics and outcomes of patients with COVID-19 and rheumatic disease in China 'hot spot' versus in US 'hot spot': similarities and differences' by Zhao et al.
D'Silva KM, Serling-Boyd N, Wallwork R, Hsu T, Sparks JA, Wallace ZS. D'Silva KM, et al. Among authors: hsu t. Ann Rheum Dis. 2021 May;80(5):e64. doi: 10.1136/annrheumdis-2020-218196. Epub 2020 Jun 16. Ann Rheum Dis. 2021. PMID: 32546600 No abstract available.
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry.
Strangfeld A, Schäfer M, Gianfrancesco MA, Lawson-Tovey S, Liew JW, Ljung L, Mateus EF, Richez C, Santos MJ, Schmajuk G, Scirè CA, Sirotich E, Sparks JA, Sufka P, Thomas T, Trupin L, Wallace ZS, Al-Adely S, Bachiller-Corral J, Bhana S, Cacoub P, Carmona L, Costello R, Costello W, Gossec L, Grainger R, Hachulla E, Hasseli R, Hausmann JS, Hyrich KL, Izadi Z, Jacobsohn L, Katz P, Kearsley-Fleet L, Robinson PC, Yazdany J, Machado PM; COVID-19 Global Rheumatology Alliance. Strangfeld A, et al. Ann Rheum Dis. 2021 Jul;80(7):930-942. doi: 10.1136/annrheumdis-2020-219498. Epub 2021 Jan 27. Ann Rheum Dis. 2021. PMID: 33504483 Free PMC article.
COVID-19 Outcomes Among Users of CD20 Inhibitors for Immune-Mediated Diseases: A Comparative Cohort Study.
Patel NJ, D'Silva KM, Hsu TY, DiIorio M, Fu X, Cook C, Prisco L, Martin L, Vanni KMM, Zaccardelli A, Zhang Y, Sparks JA, Wallace ZS. Patel NJ, et al. Among authors: hsu ty. medRxiv [Preprint]. 2021 Aug 9:2021.08.05.21261643. doi: 10.1101/2021.08.05.21261643. medRxiv. 2021. Update in: ACR Open Rheumatol. 2022 Mar;4(3):238-246. doi: 10.1002/acr2.11386 PMID: 34401883 Free PMC article. Updated. Preprint.
Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study.
Sattui SE, Conway R, Putman MS, Seet AM, Gianfrancesco MA, Beins K, Hill C, Liew D, Mackie SL, Mehta P, Neill L, Gomez G, Salinas MIH, Maldonado FN, Mariz HA, de Sousa Studart SA, Araujo NC, Knight A, Rozza D, Quartuccio L, Samson M, Bally S, Maria AT, Chazerain P, Hasseli R, Müller-Ladner U, Hoyer BF, Voll R, Torres RP, Luis M, Ribeirio SLE, Al-Emadi S, Sparks JA, Hsu TY, D'Silva KM, Patel NJ, Wise L, Gilbert E, Almada MV, Duarte-García A, Ugarte-Gil M, Jacobsohn L, Izadi Z, Strangfeld A, Mateus EF, Hyrich KL, Gossec L, Carmona L, Lawson-Tovey S, Kearsley-Fleet L, Schaefer M, Sirotich E, Hausmann JS, Sufka P, Bhana S, Liew JW, Grainger R, Machado PM, Wallace ZS, Yazdany J, Robinson PC; Global Rheumatology Alliance. Sattui SE, et al. Among authors: hsu ty. Lancet Rheumatol. 2021 Dec;3(12):e855-e864. doi: 10.1016/S2665-9913(21)00316-7. Epub 2021 Nov 5. Lancet Rheumatol. 2021. PMID: 34778843 Free PMC article.
DMARD disruption, disease flare, and prolonged symptom duration after acute COVID-19 among participants with rheumatic disease: A prospective study.
Di Iorio M, Cook CE, Vanni KMM, Patel NJ, D'Silva KM, Fu X, Wang J, Prisco LC, Kowalski E, Zaccardelli A, Martin LW, Qian G, Hsu TY, Wallace ZS, Sparks JA. Di Iorio M, et al. Among authors: hsu ty. medRxiv [Preprint]. 2022 Feb 9:2022.02.08.22270696. doi: 10.1101/2022.02.08.22270696. medRxiv. 2022. Update in: Semin Arthritis Rheum. 2022 Aug;55:152025. doi: 10.1016/j.semarthrit.2022.152025 PMID: 35169813 Free PMC article. Updated. Preprint.
Temporal trends in COVID-19 outcomes in people with rheumatic diseases in Ireland: data from the COVID-19 Global Rheumatology Alliance registry.
Conway R, Nikiphorou E, Demetriou CA, Low C, Leamy K, Ryan JG, Kavanagh R, Fraser AD, Carey JJ, O'Connell P, Flood RM, Mullan RH, Kane DJ, Ambrose N, Stafford F, Robinson PC, Liew JW, Grainger R, McCarthy GM; COVID-19 Global Rheumatology Alliance. Conway R, et al. Rheumatology (Oxford). 2022 Jun 28;61(SI2):SI151-SI156. doi: 10.1093/rheumatology/keac142. Rheumatology (Oxford). 2022. PMID: 35258593 Free PMC article.
Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: From the first wave to Omicron.
Kawano Y, Patel NJ, Wang X, Cook CE, Vanni KMM, Kowalski EN, Banasiak EP, Qian G, DiIorio M, Hsu TYT, Weinblatt ME, Todd DJ, Wallace ZS, Sparks JA. Kawano Y, et al. Among authors: hsu tyt. medRxiv [Preprint]. 2022 Jun 20:2022.06.19.22276599. doi: 10.1101/2022.06.19.22276599. medRxiv. 2022. Update in: Ann Rheum Dis. 2022 Dec;81(12):1742-1749. doi: 10.1136/ard-2022-222954 PMID: 35765565 Free PMC article. Updated. Preprint.
Earlier vs. later time period of COVID-19 infection and emergent autoimmune signs, symptoms, and serologies.
Oakes EG, Dillon E, Buhler KA, Guan H, Paudel M, Marks K, Adejoorin I, Yee J, Ellrodt J, Tedeschi S, Sparks J, Case SM, Hsu T, Solomon DH, Jonsson AH, Alexander RV, Rao DA, Choi MY, Costenbader KH. Oakes EG, et al. Among authors: hsu t. J Autoimmun. 2024 Sep;148:103299. doi: 10.1016/j.jaut.2024.103299. Epub 2024 Aug 2. J Autoimmun. 2024. PMID: 39096716
2,917 results